I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Fontoura, Paulo
572
results:
OpenAccess-fulltext X
Search for persons
X
Languages
english (184)
more...
portuguese (164)
french (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Correction to: Two‑year efficacy and safety of risdiplam in..:
Oskoui, Maryam
;
Day, John W
;
Deconinck, Nicolas
...
https://freidok.uni-freiburg.de/data/235819. , 2023
Link:
https://freidok.uni-frei..
?
2
Two-year efficacy and safety of risdiplam in patients with ..:
Oskoui, Maryam
;
Day, John W
;
Deconinck, Nicolas
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897618/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
3
Correction to: Two‑year efficacy and safety of risdiplam in..:
Oskoui, Maryam
;
Day, John W
;
Deconinck, Nicolas
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129951/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
4
Two-year efficacy and safety of risdiplam in patients with ..:
Oskoui, Maryam
;
Day, John W
;
Deconinck, Nicolas
...
https://discovery.ucl.ac.uk/id/eprint/10164626/2/Baranello_s00415-023-11560-1.pdf. , 2023
Link:
https://discovery.ucl.ac..
?
5
Two-year efficacy and safety of risdiplam in patients with ..:
Oskoui, Maryam
;
Day, John W
;
Deconinck, Nicolas
...
https://freidok.uni-freiburg.de/data/234008. , 2023
Link:
https://freidok.uni-frei..
?
6
FIGURE 4 in First record of a deep-sea tardigrade from the ..:
Bai, Lifen
;
Wang, Xiaogu
;
Gao, Xiaohui
..
doi:10.11646/zootaxa.5159.3.7. , 2022
Link:
https://zenodo.org/recor..
?
7
FIGURE 5 in First record of a deep-sea tardigrade from the ..:
Bai, Lifen
;
Wang, Xiaogu
;
Gao, Xiaohui
..
doi:10.11646/zootaxa.5159.3.7. , 2022
Link:
https://zenodo.org/recor..
?
8
FIGURE 2 in First record of a deep-sea tardigrade from the ..:
Bai, Lifen
;
Wang, Xiaogu
;
Gao, Xiaohui
..
doi:10.11646/zootaxa.5159.3.7. , 2022
Link:
https://zenodo.org/recor..
?
9
Gantenerumab ; Gantenerumab: an anti-amyloid monoclonal ant..:
Bateman, Randall, J
;
Cummings, Jeffrey
;
Schobel, Scott
...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13195-022-01110-8. , 2022
Link:
https://ut3-toulouseinp...
?
10
Gantenerumab: an anti-amyloid monoclonal antibody with pote..:
Bateman, Randall J
;
Cummings, Jeffrey
;
Schobel, Scott
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707418/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
11
Halechiniscus janus Bai & Wang & Gao & Li & Fontoura 2022, ..:
Bai, Lifen
;
Wang, Xiaogu
;
Gao, Xiaohui
..
info:eu-repo/semantics/altIdentifier/url/http://treatment.plazi.org/id/03A68789AA391C2EA29B4C8FFD78FDE5. , 2022
Link:
https://zenodo.org/recor..
?
12
FIGURE 1 in First record of a deep-sea tardigrade from the ..:
Bai, Lifen
;
Wang, Xiaogu
;
Gao, Xiaohui
..
doi:10.11646/zootaxa.5159.3.7. , 2022
Link:
https://zenodo.org/recor..
?
13
Trial of Prasinezumab in Early-Stage Parkinson's Disease:
Pagano, Gennaro
;
Taylor, Kirsten I
;
Mollenhauer, Brit
...
info:eu-repo/semantics/altIdentifier/doi/10.34734/FZJ-2022-03262. , 2022
Link:
https://juser.fz-juelich..
?
14
A trial of gantenerumab or solanezumab in dominantly inheri..:
Salloway, Stephen
;
Farlow, Martin
;
McDade, Eric
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988051/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
15
A Phase II Study to Evaluate the Safety and Efficacy of Pra..:
Pagano, Gennaro
;
Boess, Frank G
;
Taylor, Kirsten I
...
qt2tv8r5dg. , 2021
Link:
https://escholarship.org..
1-15